These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8271019)

  • 1. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.
    Hirashima Y; Endo S; Ohmori T; Kato R; Takaku A
    J Neurosurg; 1994 Jan; 80(1):31-6. PubMed ID: 8271019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.
    Hirashima Y; Endo S; Kurimoto M; Tsukamoto E; Takaku A
    Acta Neurochir (Wien); 1994; 128(1-4):144-9. PubMed ID: 7847132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma platelet-activating factor-acetyl hydrolase activity and the levels of free forms of biomarker of lipid peroxidation in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.
    Hirashima Y; Doshi M; Hayashi N; Endo S; Akazawa Y; Shichiri M; Yoshida Y
    Neurosurgery; 2012 Mar; 70(3):602-9. PubMed ID: 21866060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)].
    Wang R; Zhang XJ; Hu XL; Zhao XH
    Se Pu; 1999 Nov; 17(6):590-2. PubMed ID: 12552702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM
    J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma.
    Seifert V; Löffler BM; Zimmermann M; Roux S; Stolke D
    J Neurosurg; 1995 Jan; 82(1):55-62. PubMed ID: 7815135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
    Parks JE; Hough SR
    J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients.
    Kaye AH; Tagari PC; Teddy PJ; Adams CB; Blaso WP; Boullin DJ
    J Neurosurg; 1984 May; 60(5):927-34. PubMed ID: 6716160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytosolic free calcium elevation in rat vascular smooth-muscle cells by cerebrospinal fluid from patients after subarachnoid hemorrhage.
    Takenaka K; Yamada H; Sakai N; Ando T; Nakashima T; Nishimura Y
    J Neurosurg; 1991 Sep; 75(3):452-7. PubMed ID: 1869947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
    Satoh K; Imaizumi T; Yoshida H; Takamatsu S
    J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
    Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
    J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
    Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
    J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage.
    Ikeda K; Asakura H; Futami K; Yamashita J
    Neurosurgery; 1997 Aug; 41(2):344-9; discussion 349-50. PubMed ID: 9257301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl)].
    Niizuma H; Kwak R; Ohi T; Katakura R; Mizoi K; Suzuki J
    No Shinkei Geka; 1978 Aug; 6(8):749-55. PubMed ID: 724078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.
    Hirashima Y; Endo S; Otsuji T; Karasawa K; Nojima S; Takaku A
    J Neurosurg; 1993 Apr; 78(4):592-7. PubMed ID: 8450333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Suzuki R; Masaoka H; Hirata Y; Marumo F; Isotani E; Hirakawa K
    J Neurosurg; 1992 Jul; 77(1):96-100. PubMed ID: 1607979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
    Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M
    Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
    Ostermann G; Kostner GM; Gries A; Malle E; Till U
    Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor acetylhydrolase activity in seminal plasma from the bull, stallion, rabbit, and rooster.
    Hough SR; Parks JE
    Biol Reprod; 1994 Apr; 50(4):912-6. PubMed ID: 8199270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
    Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
    J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.